Patient Buzz Series: Pandemic and Protests
Consumer news articles are revealing patients’ questions about the impact of the deadly pandemic and nationwide protests on their skin, hair, and nail health. How can you prevent breakouts from wearing face masks? Should you avoid oil-based beauty products while protesting? Is ‘COVID toe’ not actually caused by COVID-19?
Be prepared for your patients’ questions about these timely dermat …
Consumer news articles are revealing patients’ questions about the impact of the deadly pandemic and nationwide protests on their skin, hair, and nail health. How can you prevent breakouts from wearing face masks? Should you avoid oil-based beauty products while protesting? Is ‘COVID toe’ not actually caused by COVID-19?
Be prepared for your patients’ questions about these timely dermat … Continue reading "Patient Buzz Series: Pandemic and Protests"
This 32-year-old man has two sisters each with melanoma, and his father died from metastatic pancreatic cancer. You suspect a germline mutation in which of the following genes?
A. BAP1
B. TERT
C. MITF
D. CDKN2A
E. PTCH
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
Melanoma remains the most common cause of death among skin cancers. Over the past decade, major leaps have been made in treating advanced melanoma, resulting in unprecedented improvement in survival. Nevertheless, a large room for improvement is still ahead. In his presentation Therapeutic Updates in Melanoma: IO for Earlier Stage Disease presented at the 2020 ODAC Dermatology, Aesthetic and Sur … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference interviewed Dr. Adam Friedman, Professor, Interim Chair of Dermatology, and Residency Program Director at George Washington University, on some of the common misconceptions and controversies surrounding photoprotection.
With ample evidence today that shows that sunscreen both reduces the incidence of me … 
Have you ever come across a patient with a skin cancer that you are not 100% sure should be treated with Mohs surgery or an alternative modality? Or a patient who comes back for a follow-up after skin cancer surgery with an undesirable scar and you wonder if you should have opted for a less invasive option? I certainly have. Some of these nagging questions were answered by a thoughtful, case-based … 